{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:53:32Z","timestamp":1793170412895,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["UNCE 204064"],"award-info":[{"award-number":["UNCE 204064"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PROGRES Q26\/LF1"],"award-info":[{"award-number":["PROGRES Q26\/LF1"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"crossref","award":["RVO-VFN 64165\/2012"],"award-info":[{"award-number":["RVO-VFN 64165\/2012"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00415-019-09364-3","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T15:49:11Z","timestamp":1557503351000},"page":"1953-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay\u2013Sachs disease"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-7648","authenticated-orcid":false,"given":"Helena","family":"Jahnov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Poup\u011btov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Jire\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Vl\u00e1\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ko\u0161\u0165\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Mazanec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Zumrov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Me\u010d\u00ed\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Mu\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-9509","authenticated-orcid":false,"given":"Martin","family":"Magner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"9364_CR1","unstructured":"Gravel RA, Kaback MM, Proia RL, et al (2014) The GM2 Gangliosidoses. In: The online metabolic and molecular bases of inherited diseases"},{"key":"9364_CR2","unstructured":"Kaback MM, Desnick RJ (2011) Hexosaminidase A deficiency. In: Pagon R, Adam M (eds) GenReviews, pp 1993\u20132018"},{"key":"9364_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.survophthal.2013.02.005","volume":"59","author":"H Chen","year":"2014","unstructured":"Chen H, Chan AY, Stone DU, Mandal NA (2014) Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. Surv. Ophthalmol. 59:64\u201376","journal-title":"Surv. Ophthalmol."},{"key":"9364_CR4","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1097\/00006254-199405000-00013","volume":"270","author":"M Kaback","year":"1994","unstructured":"Kaback M, Lim-Steele J, Dabholkar D et al (1994) Tay\u2013Sachs disease\u2014carrier screening, prenatal diagnosis and the molecular era: an international perspective, 1970 to 1993. Obstet Gynecol Surv 270:2307\u20132315. \n                    https:\/\/doi.org\/10.1097\/00006254-199405000-00013","journal-title":"Obstet Gynecol Surv"},{"key":"9364_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/PL00014401","volume":"159","author":"MM Kaback","year":"2000","unstructured":"Kaback MM (2000) Population-based genetic screening for reproductive counseling: the Tay\u2013Sachs disease model. Eur J Pediatr 159:192\u2013195. \n                    https:\/\/doi.org\/10.1007\/PL00014401","journal-title":"Eur J Pediatr"},{"key":"9364_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/humu.21327","volume":"31","author":"SA Scott","year":"2010","unstructured":"Scott SA, Edelmann L, Liu L et al (2010) Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 31:1240\u20131250. \n                    https:\/\/doi.org\/10.1002\/humu.21327","journal-title":"Hum Mutat"},{"key":"9364_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","volume":"7","author":"O Neudorfer","year":"2005","unstructured":"Neudorfer O, Pastores GM, Zeng BJ et al (2005) Late-onset Tay\u2013Sachs disease: phenotypic characterization and genotypic correlation in 21 affected patients. Genet Med 7:119\u2013123","journal-title":"Genet Med"},{"key":"9364_CR8","first-page":"5","volume":"31","author":"KM Steiner","year":"2016","unstructured":"Steiner KM, Brenck J, Goericke S, Timmann D (2016) Cerebellar atrophy and muscle weakness: late-onset Tay\u2013Sachs disease outside Jewish populations. BMJ Case Rep 31:5","journal-title":"BMJ Case Rep"},{"key":"9364_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/practneurol-2017-001665","volume":"17","author":"AW Barritt","year":"2017","unstructured":"Barritt AW, Anderson SJ, Leigh PN, Ridha BH (2017) Late-onset Tay\u2013Sachs disease. Pract Neurol 17:396\u2013399. \n                    https:\/\/doi.org\/10.1136\/practneurol-2017-001665","journal-title":"Pract Neurol"},{"key":"9364_CR10","first-page":"221","volume":"76","author":"I Prihodova","year":"2013","unstructured":"Prihodova I, Kalincik T, Poupetova H et al (2013) Late-onset Tay\u2013Sachs disease can mimic spinal muscular atrophy type III\u2014two case reports. Ces a Slov Neurol a Neurochir 76:221\u2013224","journal-title":"Ces a Slov Neurol a Neurochir"},{"key":"9364_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ajmg.1320240123","volume":"24","author":"R Navon","year":"1986","unstructured":"Navon R, Argov Z, Frisch A (1986) Hexosaminidase A deficiency in adults. Am J Med Genet 24:179\u2013196. \n                    https:\/\/doi.org\/10.1002\/ajmg.1320240123","journal-title":"Am J Med Genet"},{"key":"9364_CR12","first-page":"587","volume-title":"Techniques in diagnostic human biochemical genetics","author":"D Wenger","year":"1991","unstructured":"Wenger D, Williams C (1991) Screening for lysosomal disorders. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics. Willey-Liss, New York, pp 587\u2013617"},{"key":"9364_CR13","unstructured":"HEXA hexosaminidase subunit alpha [Homo sapiens (human)]. \n                    https:\/\/www.ncbi.nlm.nih.gov\/gene\/3073\n                    \n                  . Accessed 30 Sep 2018"},{"key":"9364_CR14","unstructured":"Human genom variation society. \n                    https:\/\/www.hgvs.org\/\n                    \n                  . Accessed 17 Sep 2018"},{"key":"9364_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1192\/bjp.155.3.410","volume":"155","author":"J Streifler","year":"1989","unstructured":"Streifler J, Golomb M, Gadoth N (1989) Psychiatric features of adult GM2gangliosidosis. Br J Psychiatry 155:410\u2013413. \n                    https:\/\/doi.org\/10.1192\/bjp.155.3.410","journal-title":"Br J Psychiatry"},{"key":"9364_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1176\/jnp.10.1.10","volume":"10","author":"GM MacQueen","year":"1998","unstructured":"MacQueen GM, Rosebush PI, Mazurek MF (1998) Neuropsychiatric aspects of the adult variant of Tay\u2013Sachs disease. J Neuropsychiatry Clin Neurosci 10:10\u201319. \n                    https:\/\/doi.org\/10.1176\/jnp.10.1.10","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9364_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1126\/science.2522679","volume":"243","author":"R Navon","year":"1989","unstructured":"Navon R, Proia RL (1989) The mutations in Ashkenazi Jews with adult GM2gangliosidosis, the adult form of Tay\u2013Sachs disease. Science 243:1471\u20131474. \n                    https:\/\/doi.org\/10.1126\/science.2522679","journal-title":"Science"},{"key":"9364_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/8904_2017_76","volume":"41","author":"KM Stepien","year":"2017","unstructured":"Stepien KM, Lum SH, Wraith JE et al (2017) Haematopoietic stem cell transplantation arrests the progression of neurodegenerative disease in late-onset Tay\u2013Sachs disease. JIMD Rep 41:17\u201323. \n                    https:\/\/doi.org\/10.1007\/8904_2017_76","journal-title":"JIMD Rep"},{"key":"9364_CR19","first-page":"107","volume":"6","author":"O Neudorfer","year":"2004","unstructured":"Neudorfer O, Kolodny EH (2004) Late-onset Tay\u2013Sachs disease. Isr Med Assoc J 6:107\u2013111","journal-title":"Isr Med Assoc J"},{"key":"9364_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.29.6.848","volume":"29","author":"BU von Specht","year":"1979","unstructured":"von Specht BU, Geiger B, Arnon R et al (1979) Enzyme replacement in Tay\u2013Sachs disease. Neurology 29:848\u2013854. \n                    https:\/\/doi.org\/10.1212\/WNL.29.6.848","journal-title":"Neurology"},{"key":"9364_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/GIM.0b013e3181a1b5c5","volume":"11","author":"BE Shapiro","year":"2009","unstructured":"Shapiro BE, Pastores GM, Gianutsos J et al (2009) Miglustat in late-onset Tay\u2013Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genet Med 11:425\u2013433. \n                    https:\/\/doi.org\/10.1097\/GIM.0b013e3181a1b5c5","journal-title":"Genet Med"},{"key":"9364_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13023-015-0260-7","volume":"17","author":"E Osher","year":"2015","unstructured":"Osher E, Fattal-Valevski A, Sagie L et al (2015) Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study. Orphanet J Rare Dis 17:10\u201345. \n                    https:\/\/doi.org\/10.1186\/s13023-015-0260-7","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09364-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:14:40Z","timestamp":1588965280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09364-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9364"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09364-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"2 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}